Description: This webinar, presented by Dr. Robert Schreiber, addresses how mouse and human cancers have been used to identify therapeutically useful tumor neoantigens; how these neoantigens can form the basis for personalized cancer vaccines; and what additional forms of therapy are needed to optimize the therapeutic effects of personalized cancer vaccines.